Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics

1

In 2020, China reported 4.57 million new cancer cases, with projections indicating a rise to 28.40 million by 2040.
2

Cardiotoxicity from anticancer drugs significantly contributes to mortality in cancer patients, necessitating interdisciplinary approaches in cardio-oncology.
3

The Chinese Medical Association developed guidelines to standardize pharmaceutical management in combined cardio-oncology clinics involving physicians and pharmacists.
4

Sichuan Provincial People’s Hospital established a physician-pharmacist clinic to ensure rational drug use in cancer patients amid rising cardiovascular complications.
5

The Consensus on Pharmaceutical Management was formulated through expert collaboration and systematic evidence retrieval to enhance pharmacotherapy safety and effectiveness.

1